1Marin Aguilera M, Mengual I., Ribal MJ,et al. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer[J]. Cancer Genet Cytogenet,2007,173(2) : 131-135.
2Ramakumar S, Bhuiyan J, Besse JA, et al. Comparison oir screening methods in the detection of bladder cancer[J]. J Uroh 1999, 161 (2) :388-394.
3van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for blad der cancer surveillance: a systematic re view[J]. Eur Urol, 2005, 47 (6): 736-748.
4Gregoire M, Fradet Y, Meyer F, et al. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors [J]. J Urol, 1997,157(5) : 1660-1664.
3Oosterlinck W,Solsona E,van der Meijden AP,et al.EAU guide-lines on diagnosis and treatment of upper urinary tract transitionalcell carcinoma[J].Eur Urol,2004,46(2):147-154.
5Lamm DL,Riggs DR,Traynelis CL,et al.Apparent failure of cur-rent intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder[J].J Urol,1995,153(5):1444-1450.
7Ramakumar S,Bhuiyan J,Besse JA,et al.Comparison of screeningmethods in the detection of bladder cancer[J].J Urol,1999,161(2):388-394.
8Seaman EK,Slawin KM,Benson MC.Treatment options for uppertract transitional-cell carcinoma[J].Urol Cin North Am,1993,20(2):349-354.
9van Rhijn BW,van der Poel HG,van der Kwast TH.Urine markersfor bladder cancer surveillance:a systematic review[J].Eur Urol,2005,47(6):736-748.
10Galván AB,Salido M,Espinet B,et al.A multicolor fluorescence insitu hybridization assay:A monitoring tool in the surveillance of pa-tients with a history of non-muscle-invasive urothelial cell carcino-ma:A prospective study[J].Cancer Cytopathol,2011,119(6):395-403.
